You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 65 No. 12, December 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Abstract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease

Roberto Cilia, MD; Chiara Siri, PsyD; Giorgio Marotta, MD; Ioannis U. Isaias, MD; Danilo De Gaspari, PsyD; Margherita Canesi, MD; Gianni Pezzoli, MD; Angelo Antonini, MD

Arch Neurol. 2008;65(12):1604-1611.

ABSTRACT



Background  Pathological gambling (PG) may develop in patients with Parkinson disease (PD) during dopamine replacement therapy, but the underlying neural correlates are still unclear.

Objective  To investigate resting state brain perfusion in PD patients with active PG compared with matched PD controls and healthy controls.

Design  Case-control study.

Setting  Outpatient tertiary clinic.

Participants  Eleven right-handed PD patients with active PG according to Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision) criteria, 40 matched PD controls, and 29 age-matched healthy controls.

Intervention  All the participants underwent resting state brain perfusion single-photon emission computed tomography using technetium TC 99m ethylcysteinate dimer bicisate. All PD subjects were taking dopaminergic medication.

Main Outcome Measure  Statistical Parametric Mapping was used for data analysis (P < .005, false discovery rate corrected).

Results  PD patients with PG showed resting state overactivity in a right hemisphere network that included the orbitofrontal cortex, the hippocampus, the amygdala, the insula, and the ventral pallidum. No areas of perfusion reduction were detected.

Conclusions  We found that PD patients with PG have abnormal resting state dysfunction of the mesocorticolimbic network possibly associated with a drug-induced overstimulation of relatively preserved reward-related neuronal systems. These findings support the concept that PG is a "behavioral" addictive disorder.



INTRODUCTION


 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Pathological gambling (PG) is defined by failure to resist the urge to gamble, with persistent and recurrent maladaptive gambling behavior despite disruptive consequences on familial, occupational, and social functions. It is classified as an impulse control disorder (ICD) in the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision)1 and is reported in patients with Parkinson disease (PD) in association with dopamine replacement therapy (DRT).2-3

Imaging studies4 in PG have demonstrated abnormal functioning in the prefrontal and limbic brain areas during gambling-related activation tasks. ICDs (including PG) in PD are associated with specific traits, such as high impulsivity5 and novelty seeking.3 Several studies6-8 on impulsivity and addiction have underlined the critical role of brain pathways in the development of compulsive reward-seeking behaviors, whereas the role of dopamine neuron loss and medications in the occurrence of ICDs in PD is debated.3, 9 Indeed, whereas untreated PD patients display an abnormal response to monetary reward secondary to reduced dopamine availability in the mesocorticolimbic pathways,10 DRT may increase impulsivity and sensitivity to reward.11-12

In the present study, we used perfusion single-photon emission computed tomography (SPECT) to determine whether PD patients with PG exhibit differential brain activity compared with matched PD controls and healthy controls.


METHODS


 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

PATIENTS

We included outpatients with PD13 who attended the Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy, from January 2004 to January 2007. Patients and their caregivers were interviewed about gambling and other ICDs during routine neurologic examination, and if behavioral problems were suspected, patients underwent additional evaluations by 2 trained neuropsychologists (C.S. and D.D.G.). Diagnosis of PG was established according to Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision) criteria. All PD patients were screened using the Mini-Mental State Examination, the Frontal Assessment Battery, the Raven Colored Progressive Matrices, the Geriatric Depression Scale, and the South Oaks Gambling Screen (SOGS). All SOGS scores greater than 5 were considered to be pathological.14 We excluded patients with cognitive impairment (Mini-Mental State Examination score <24 corrected), previous neurosurgical procedures, or a history of PG before PD onset and those who developed PG after the initiation of DRT but who were no longer symptomatic when examined. We also excluded all individuals treated with psychoactive drugs other than dopaminergic medications (levodopa and/or dopamine agonists). None of the patients had the hedonistic homeostatic dysregulation syndrome.15 Clinical assessment included the Unified Parkinson Disease Rating Scale motor score and the Hoehn and Yahr stage while taking medication. All the patients were taking stable doses of DRT during the previous 6 months, and individual daily medication dose was calculated as the sum of the levodopa and dopamine agonists converted into levodopa-equivalent daily dose5 (Table 1). We compared imaging data with age-matched selected nondemented PD patients with comparable demographic and clinical features who underwent the same evaluation as pathological gamblers and had not manifested significant frontal lobe dysfunction or behavioral problems (Table 2). All of these individuals were right-handed and had SOGS scores less than 3. Informed consent was obtained from each participant according to the Declaration of Helsinki. The study was approved by the ethics committee of the Istituti Clinici di Perfezionamento, Milan.


View this table:
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Table 1. Clinical and Gambling-Related Features of 11 PD Patients With Pathological Gambling



View this table:
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Table 2. Clinical Features of PD Gamblers, PD Controls, and Healthy Controls


SPECT IMAGING AND DATA ANALYSIS

All of the images were obtained in the morning during medication use, while in the resting condition with closed eyes. Brain SPECT studies were acquired using a dedicated triple-detector gamma camera (Prism 3000; Philips Medical Systems, Best, the Netherlands) equipped with ultra-high-resolution fan beam collimators. Six fast SPECT acquisitions (matrix size, 128 x 128; pixel size, 2.0-2.4 mm; radius of rotation, 12.9-13.9 cm; and duration, 20 minutes) were started 30 to 60 minutes after intravenous injection of approximately 740 MBq of technetium TC 99m ethylcysteinate dimer bicisate (Neurolite; Bristol-Myers Squibb Medical Imaging, North Billerica, Massachusetts) with patients sitting with closed eyes in a quiet and dimly lit room, according to a standardized protocol.16

The SPECT images were reconstructed by means of an iterative algorithm (ordered subset expectation-maximization, 20 iterations and 15 subsets), filtered using a 3-dimensional Butterworth filter (order, 5; cutoff frequency, 0.31 cycles/pixel). Attenuation was corrected by means of the Chang method (attenuation coefficient, µ = 0.1 cm – 1) for Statistical Parametric Mapping (SPM2; Wellcome Department of Imaging Neuroscience, London, England). The SPECTs of PD patients and healthy controls were spatially normalized to the standard SPECT template embedded in SPM2. All of the images were then smoothed using a full-width half-maximum 12-mm gaussian kernel to increase the signal-to-noise ratio and to account for subtle variations in anatomical structures. The level of significance of cerebral areas with regional cerebral blood flow (rCBF) changes was assessed by means of the spatial extent and the peak height (z score) of their clusters using estimations based on the theory of random gaussian fields.

A general linear model was used to perform the appropriate voxel-by-voxel statistics using SPM2 in whole brain of all the participants. The analysis was applied to SPECT images by means of single-subject: conditions and covariates design: the 3 groups of PD gamblers, PD controls, and healthy controls were modeled as conditions, with age as the nuisance variable. The effect of global differences in blood flow was removed by using the proportional scaling global mean to 50, with the threshold masking relative to the default value of 0.8. All voxel-based statistical analyses were performed by applying a threshold of P < .005, corrected for false discovery rate, for significance and considering clusters of at least 50 voxels. The coordinates of the most significant voxel in a cluster were converted from the Montreal Neurological Institute standard coordinates used by SPM to Talairach coordinates, and their location was investigated using Talairach Daemon software.17

Comparisons between continuous variables in PD gamblers, PD controls, and healthy controls were performed using the unpaired t test (P < .05), and the {chi}2 test was used for categorical variables (P < .05). Statistical analysis was performed using a software program (SPSS for Windows Release 10.0; SPSS Inc, Chicago, Illinois).


RESULTS


 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

We investigated 11 selected PD patients (mean [SD] age, 57 [6] years; age range, 46-67 years) with active PG according to the inclusion criteria. All identified patients were high-frequency gamblers (more than 1 gambling episode per week), and neuropsychological assessment excluded significant frontal lobe dysfunction or depression. Detailed features of each PD gambler are reported in Table 1. There were no differences between PD gamblers and both control groups for all of the demographic and clinical features listed in Table 2, except for higher SOGS scores (P < .001).

PD GAMBLERS VS PD CONTROLS

SPM2 analysis showed several clusters of increased perfusion in PD gamblers, mainly in the right hemisphere, but no area of relative reduced perfusion (Figure 1, Figure 2, and Table 3). We found a cluster of 557 voxels with a peak located in the right lateral orbitofrontal cortex (OFC) and extended to the insula. There were rCBF increases in the right hippocampus extended to the parahippocampal gyrus and also encompassing the amygdala (Figure 1A). Moreover, there were increases in a cluster located in the ventral basal ganglia on the right hemisphere, with a peak in the globus pallidus, and extended to the nucleus accumbens (Figure 1B). Enhanced rCBF was also found in the left insula and in the bilateral precuneus, extending to the cuneus and the posterior cingulate cortex.


Figure 1
View larger version (42K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Areas of significantly increased blood flow in Parkinson disease (PD) patients with pathological gambling vs PD controls obtained from whole-brain Statistical Parametric Mapping analysis (P < .005, false discovery rate corrected). The crossbars indicate the voxel with the peak of significance in the hippocampus/amygdala cluster. The cluster of increased perfusion in the right orbitofrontal cortex is also present on axial view. L indicates left; R, right.



Figure 2
View larger version (72K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Areas of significantly increased blood flow in Parkinson disease (PD) patients with pathological gambling vs PD controls obtained from whole-brain Statistical Parametric Mapping analysis (P < .005, false discovery rate corrected). The crossbars indicate the voxel with the peak of significance in the ventral pallidum cluster, extending to the nucleus accumbens. The cluster of increased perfusion in the right insula is also present on axial view. L indicates left; R, right.



View this table:
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Table 3. Anatomical Locations, Talairach Atlas Coordinates, Height Threshold, Spatial Extent of Clusters in Voxels With rCBF Increments, and z Scores of Maximal Activation


PD GAMBLERS VS HEALTHY CONTROLS

SPM analysis detected 2 large clusters of increased perfusion in the right hemisphere without areas of reduced perfusion (Figure 3 and Table 3). We found a large cluster (955 voxels) with a peak in the insular cortex extended to the lateral OFC and also involving the putamen and the caudate nucleus. Another cluster (163 voxels) was present in the right hippocampus extending to the parahippocampal gyrus.


Figure 3
View larger version (69K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Areas of significantly increased blood flow in Parkinson disease patients with pathological gambling vs healthy controls obtained from whole-brain Statistical Parametric Mapping analysis (P < .005, false discovery rate corrected). The crossbars indicate the voxel with the peak of significance in the right insula. L indicates left; R, right.


PD CONTROLS VS HEALTHY CONTROLS

Nongambling PD controls showed reduced perfusion in the frontal lobe bilaterally, the right parietooccipital cortical areas, and the left thalamus compared with age-matched healthy controls. Clusters of increased rCBF were found in the cerebellum bilaterally (Table 3).


COMMENT


 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

This is the first investigation, to our knowledge, of resting cerebral perfusion in a selected cohort of PD patients with active PG. We previously demonstrated the reliability of this approach in assessing cerebral activity in PD.16 The PD gamblers showed significant overactivity in brain areas critically involved in reward and reward-based learning, motivation, impulse control, decision making, and memory processing, namely, the basal ganglia, the OFC, the hippocampus, the amygdala, and the insula.6-7 This pattern of activity increments is similar in PD gamblers and in the PD and non-PD control groups and suggests specific functional abnormalities in the mesocorticolimbic network.

The lack of significant rCBF decrements in PD gamblers is an intriguing finding given that perfusion reductions in the cortical areas found in PD controls vs healthy individuals have been described as a result of the neurodegenerative process.18 In the present study, we applied strict inclusion criteria, and PD controls were selected to have similar demographic characteristics, disease-related features, cognitive function, dose range, and type of medication use to those of the PG cohort to minimize possible confounding effects. Therefore, the absence of a significant cerebral activity decrement in PD gamblers suggests relatively preserved neuronal systems in the presence of nigrostriatal impairment similar to PD controls.12 Pathological gambling may develop as a consequence of an abnormal drug-induced overstimulation in PD individuals with a relatively spared mesocorticolimbic network.11-12 This hypothesis would be consistent with reports of PG in patients without neurodegenerative diseases (eg, restless legs syndrome) treated with low doses of dopamine agonists.19

Patients with PD taking dopaminergic medications commonly experience a mild to moderate nonpathological increment of the physiologic drive toward natural rewards,11-12 but only some individuals eventually develop ICDs. It is likely that common predisposing factors between ICDs and substance use disorders favor switching from occasional to compulsive reward-seeking addictive behaviors.7 Indeed, differences in trait reward sensitivity and motivation levels in individuals with other ICDs and substance use disorders are associated with activation of the OFC, hippocampus and amygdala, insula, and ventral pallidum.7, 20-21 Two dominant descriptive models of PG have been proposed so far, one considering it among obsessive-compulsive–spectrum disorders and another in the context of behavioral addictions.22-24 Increased resting state activity of the OFC is reported in obsessive-compulsive disorder25 and substance use disorders during early withdrawal.8 Therefore, the present findings further support the hypothesis of OFC dysfunction as a common neurobiological substrate underlying disorders characterized by poor impulse control and compulsive behaviors.8 The abnormally increased perfusion in limbic and paralimbic areas in PD gamblers might suggest a medication-induced enhancement of lower-level impulsive drive rather than a primary dysfunction of the lateral prefrontal cortex with subsequent impairment of higher-level top-down supervisory cognitive control.26 This hypothesis would also be consistent with the lack of executive dysfunction in PD patients with ICDs.9 Indeed, in this study and in a previous, more general study on ICDs,5 we found normal frontal lobe function in most PG patients.

We found significant activity changes in the ventral pallidum and not in the nucleus accumbens per se. The ventral pallidum is implicated in the modulation of hedonic responses to natural and drug rewards, and subsequent reward seeking–motivated drive by reciprocal connections with limbic areas.7, 27 The OFC function is critical in establishing the motivational value of a stimulus based on its potential reward, with a specific right-sided lateralization of conditioned responses to salient stimuli, and once activated by reward-related internal (memories) or environmental stimuli, it induces an intense urge (craving) even without activation of the nucleus accumbens.8 Craving for gambling is often reported by PD gamblers, in particular when exposed to gambling-related external stimuli or memories. The hippocampus, parahippocampal gyrus, amygdala, precuneus, and posterior cingulate cortex are all brain regions involved in memory retrieval based on previous rewarding experience,4, 28 and the insula is implicated in the processing and recall of the emotional relevance of stimuli through its reciprocal connections with the OFC, the hippocampus, and the amygdala.29 The baseline overactivity we found in brain areas related to memory processing and conditioned responses may underlie craving responses and the subsequent high risk of relapse in PG,30 as previously reported in substance use disorders.28 Moreover, OFC dysfunction is associated with impaired use of information from previous rewarding and punishing outcomes to modulate behavioral responses.31

In the present PG cohort, there was a high predominance of men, consistent with other reported case series.32 The mechanisms of male preponderance are unclear, but imaging studies have shown a stronger functional connectivity and responsiveness to rewards of the mesocorticolimbic system in males compared with females, suggesting increased vulnerability to addictive disorders.33-34

In conclusion, we hypothesize that PG occurs in PD as a result of DRT-induced overstimulation of a relatively preserved mesocorticolimbic dopamine pathway in patients with individual predisposition. The occurrence of PG may be associated with abnormal reward-based learning processes combined with reduced inhibition of impulsive drives and impaired ability to evaluate the negative consequences of financial losses. The present imaging findings support the proposal to group PG together with addictive disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders.24 Further prospective controlled studies in larger cohorts are needed to investigate the predisposing factors to the development of ICDs in patients with PD undergoing DRT (including neurobiological features and premorbid personality traits) and the clinical-functional correlates of lowering DRT.


AUTHOR INFORMATION


 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Correspondence: Roberto Cilia, MD, Parkinson Institute, Istituti Clinici di Perfezionamento, via Bignami 1, 20126 Milano, Italy (roberto.cilia{at}gmail.com).

Accepted for Publication: June 18, 2008.

Author Contributions: All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Cilia, Siri, Isaias, and Antonini. Acquisition of data: Cilia, Siri, Marotta, De Gaspari, Canesi, and Antonini. Analysis and interpretation of data: Cilia, Siri, Marotta, Pezzoli, and Antonini. Drafting of the manuscript: Cilia, Siri, and Antonini. Critical revision of the manuscript for important intellectual content: Cilia, Siri, Marotta, Isaias, De Gaspari, Canesi, Pezzoli, and Antonini. Statistical analysis: Siri and Marotta. Study supervision: Siri, Marotta, Isaias, De Gaspari, Canesi, Pezzoli, and Antonini.

Financial Disclosure: None reported.

Author Affiliations: Parkinson Institute, Istituti Clinici di Perfezionamento, Milan (Drs Cilia, Siri, Isaias, Canesi, Pezzoli, Antonini, and De Gaspari); Department of Neurology, University of Milan-Bicocca, San Gerardo Hospital, Monza (Drs Cilia and Isaias); and Nuclear Medicine, IRCCS-Ospedale Maggiore, Milan (Dr Marotta), Italy.


REFERENCES


 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Weintraub D, Siderowf AD, Potenza MN; et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63(7):969-973. FREE FULL TEXT
3. Voon V, Thomsen T, Miyasaki JM; et al. Factors associated with dopaminergic medication–related pathological gambling in Parkinson disease. Arch Neurol. 2007;64(2):212-216. FREE FULL TEXT
4. Crockford DN, Goodyear B, Edwards J, Quickfall J, el-Guebaly N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry. 2005;58(10):787-795. FULL TEXT | WEB OF SCIENCE | PUBMED
5. Isaias IU, Siri C, Cilia R; et al. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord. 2008;23(3):411-415. PUBMED
6. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159(10):1642-1652. FULL TEXT | WEB OF SCIENCE | PUBMED
7. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160(6):1041-1052. FULL TEXT | WEB OF SCIENCE | PUBMED
8. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47(suppl 1):3-13. FULL TEXT | WEB OF SCIENCE | PUBMED
9. Pagonabarraga J, García-Sánchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord. 2007;22(10):1430-1435. FULL TEXT | WEB OF SCIENCE | PUBMED
10. Künig G, Leenders KL, Martin-Sölch C, Missimer J, Magyar S, Schultz W. Reduced reward processing in the brains of parkinsonian patients. Neuroreport. 2000;11(17):3681-3687. WEB OF SCIENCE | PUBMED
11. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia. 2002;40(13):2257-2267. FULL TEXT | WEB OF SCIENCE | PUBMED
12. Cools R. Dopaminergic modulation of cognitive function: implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev. 2006;30(1):1-23. FULL TEXT | WEB OF SCIENCE | PUBMED
13. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992;42(6):1142-1146. FREE FULL TEXT
14. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry. 1987;144(9):1184-1188. WEB OF SCIENCE | PUBMED
15. Giovannoni G, O’Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry. 2000;68(4):423-428. FREE FULL TEXT
16. Cilia R, Marotta G, Landi A; et al. Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: a perfusion SPECT study. Eur J Neurol. 2008;15(1):22-28. PUBMED
17. Lancaster JL, Woldorff MG, Parsons LM; et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000;10(3):120-131. FULL TEXT | WEB OF SCIENCE | PUBMED
18. Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med. 2004;45(6):933-942. FREE FULL TEXT
19. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68(4):301-303. FREE FULL TEXT
20. Beaver JD, Lawrence AD, van Ditzhuijzen J, Davis MH, Woods A, Calder AJ. Individual differences in reward drive predict neural responses to images of food. J Neurosci. 2006;26(19):5160-5166. FREE FULL TEXT
21. Cohen MX, Krohn-Grimberghe A, Elger CE, Weber B. Dopamine gene predicts the brain's response to dopaminergic drug. Eur J Neurosci. 2007;26(12):3652-3660. WEB OF SCIENCE | PUBMED
22. Holden C. "Behavioral" addictions: do they exist? Science. 2001;294(5544):980-982. FREE FULL TEXT
23. Blanco C, Moreyra P, Nunes EV, Saiz-Ruiz J, Ibanez A. Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry. 2001;6(3):167-176. FULL TEXT | PUBMED
24. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101(suppl 1):142-151. PUBMED
25. Kwon JS, Kim JJ, Lee DW; et al. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res. 2003;122(1):37-47. FULL TEXT | WEB OF SCIENCE | PUBMED
26. McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science. 2004;306(5695):503-507. FREE FULL TEXT
27. Smith KS, Berridge KC. Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci. 2007;27(7):1594-1605. FREE FULL TEXT
28. Sell LA, Morris JS, Bearn J, Frackowiak RS, Friston KJ, Dolan RJ. Neural responses associated with cue evoked emotional states and heroin in opiate addicts. Drug Alcohol Depend. 2000;60(2):207-216. FULL TEXT | WEB OF SCIENCE | PUBMED
29. Mesulam MM, Mufson EJ. Insula of the Old World monkey, I: architectonics in the insulo-orbito-temporal component of the paralimbic brain. J Comp Neurol. 1982;212(1):1-22. FULL TEXT | WEB OF SCIENCE | PUBMED
30. Hodgins DC, el-Guebaly N. Retrospective and prospective reports of precipitants to relapse in pathological gambling. J Consult Clin Psychol. 2004;72(1):72-80. FULL TEXT | WEB OF SCIENCE | PUBMED
31. O’Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci. 2001;4(1):95-102. FULL TEXT | WEB OF SCIENCE | PUBMED
32. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation: an analysis of published case series. Mov Disord. 2007;22(12):1757-1763. FULL TEXT | WEB OF SCIENCE | PUBMED
33. Munro CA, McCaul ME, Wong DF; et al. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry. 2006;59(10):966-974. FULL TEXT | WEB OF SCIENCE | PUBMED
34. Hoeft F, Watson CL, Kesler SR, Bettinger KE, Reiss AL. Gender differences in the mesocorticolimbic system during computer game-play. J Psychiatr Res. 2008;42(4):253-258. FULL TEXT | WEB OF SCIENCE | PUBMED


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(12):1564-1565.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Imaging Approaches to Parkinson Disease
Brooks
JNM 2010;51:596-609.
ABSTRACT | FULL TEXT  

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
Thobois et al.
Brain 2010;133:1111-1127.
ABSTRACT | FULL TEXT  

Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
Wu et al.
Postgrad. Med. J. 2009;85:590-596.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.